Clinical Trials Logo
  1. Home
  2. Acute Spinal Cord Injury
  3. NCT00406016

Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI

Acute Spinal Cord Injury Clinical Trial

Official title:
A Multi-center, Open-label, Cohort Study to Assess Feasibility, Acute Safety, Tolerability and Pharmacokinetics of 4 Dose Regimens of Continuous Intrathecal ATI355 Infusion and Two Regimen of Repeated Intrathecal Bolus Injections in Acute Spinal Cord Injury Paraplegic and Tetraplegic Patients

Clinical Trial Summary

This study will evaluate the acute safety, tolerability, feasibility and pharmacokinetics of 6 dose regimens of ATI355 in acute spinal cord injury patients

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00406016
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 1
Start date May 2006
Completion date September 2011
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04811235 - Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial N/A
Recruiting NCT05305118 - TSCS for Acute SCI N/A
Recruiting NCT05244408 - "SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation
Recruiting NCT05731986 - Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI) N/A
Recruiting NCT06452264 - Early Intervention for Information Processing Speed Deficits in Acute SCI: A Pilot Study N/A
Recruiting NCT05426681 - Spinal Cord Injury Neuroprotection With Glyburide Phase 1
Recruiting NCT04056988 - tSCI Contrast Enhanced Ultrasound Study Phase 4
Recruiting NCT05745298 - The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury N/A
Terminated NCT01750684 - AC105 in Patients With Acute Traumatic Spinal Cord Injury Phase 2
Recruiting NCT04475224 - Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury Phase 3
Enrolling by invitation NCT06030531 - Spasticity and Functional Recovery After SCI
Active, not recruiting NCT03935724 - Stem Cells in Spinal Cord Injury Phase 2/Phase 3
Recruiting NCT04054414 - PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury Phase 2
Recruiting NCT06000592 - Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI N/A
Completed NCT02325414 - Prevention of Bone Loss After Acute SCI by Zoledronic Acid Phase 2
Recruiting NCT02034669 - Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment Phase 1/Phase 2
Terminated NCT02232165 - Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury N/A
Completed NCT02260713 - Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study. Phase 1/Phase 2
Terminated NCT02524379 - Spinal Cord Injury Neuroprotection With Glyburide Phase 1/Phase 2
Completed NCT01502631 - Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI) Phase 2